Matrix metalloproteinase-12 leads to elastin degradation in BALB/c mice with eosinophilic meningitis caused by Angiostrongylus cantonensis

International Journal for Parasitology

Volumn 41, Issue 11, 2011, Pages 1175-1183

  Wei, P C ^a   Tsai, C H ^a   Chiu, P S ^a   Lai, S C ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b Chung Shan University Hospital   (Taiwan)

Author keywords

Angiostrongylus cantonensis; Elastin; Eosinophilic meningitis; Matrix metalloproteinase 12

Indexed keywords

ALBENDAZOLE; DOXYCYCLINE; ELASTIN; EVANS BLUE; MACROPHAGE ELASTASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

INHIBITION; MENINGITIS; NEMATODE; PARASITE; PATHOLOGY; RODENT;

ANGIOSTRONGYLIASIS; ANGIOSTRONGYLUS CANTONENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CEREBROSPINAL FLUID; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; EOSINOPHIL COUNT; EOSINOPHIL MENINGITIS; LEUKOCYTE; MACROPHAGE; MALE; MENINGITIS; MONOTHERAPY; MOUSE; NONHUMAN; PERMEABILITY; PROTEIN CEREBROSPINAL FLUID LEVEL; SUBARACHNOID SPACE;

ANGIOSTRONGYLUS CANTONENSIS; ANIMALS; ELASTIN; EOSINOPHILIA; HUMANS; MALE; MATRIX METALLOPROTEINASE 12; MENINGITIS; MICE; MICE, INBRED BALB C; STRONGYLIDA INFECTIONS;

ANGIOSTRONGYLUS CANTONENSIS; ARENICOLA MARINA; MUS; RATTUS;

EID: 80052299230     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2011.07.002     Document Type: Article

References (39)

1. Bell M.A., Weddell A.G. A descriptive study of the blood vessels of the sciatic nerve in the rat, man and other mammals. Brain 1984, 107:871-898.
2. Bourée P., Dumazedier D., Dahane N. Angiostrongylosis or eosinophilic meningitis. Rev. Prat. 2010, 60:456-458.
3. Burggraf D., Trinkl A., Dichgans M., Hamann G.F. Doxycycline inhibits MMPs via modulation of plasminogen activators in focal cerebral ischemia. Neurobiol. Dis. 2007, 25:506-513.
4. Chen K.M., Lai S.C. Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis. J. Antimicrob. Chemother. 2007, 59:264-276.
5. Chen K.M., Lee H.H., Lu K.H., Tseng Y.K., Hsu L.S., Chou H.L., Lai S.C. Association of matrix metalloproteinase-9 and Purkinje cell degeneration in mouse cerebellum caused by Angiostrongylus cantonensis. Int. J. Parasitol. 2004, 34:1147-1156.
6. Curci J.A., Liao S., Huffman M.D., Shapiro S.D., Thompson R.W. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J. Clin. Invest. 1998, 102:1900-1910.
7. Faris B., Mozzicato P., Ferrera R., Glembourtt M., Toselli P., Franzblau C. Collagen of brain microvessel preparations. Microvasc. Res. 1982, 23:171-179.
8. Faury G., Chabaud A., Ristori M.T., Robert L., Verdetti J. Effect of age on vasodilatory action of elastin peptides. Mech. Ageing Dev. 1997, 95:31-42.
9. Goverman J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9:393-407.
10. Heinz A., Jung M.C., Duca L., Sippl W., Taddese S., Ihling C., Rusciani A., Jahreis G., Weiss A.S., Neubert R.H., Schmelzer C.E. Degradation of tropoelastin by matrix metalloproteinases-cleavage site specificities and release of matrikines. FEBS J. 2010, 277:1939-1956.
11. Hornebeck W., Brechemier D., Jacob M.P., Frances C., Robert L. On the multiplicity of cellular elastases and their inefficient control by natural inhibitors. Adv. Exp. Med. Biol. 1984, 167:111-119.
12. Hou R.F., Tu W.C., Lee H.H., Chen K.M., Chou H.L., Lai S.C. Elevation of plasminogen activators in cerebrospinal fluid of mice with eosinophilic meningitis caused by Angiostrongylus cantonensis. Int. J. Parasitol. 2004, 34:1355-1364.
13. Hsu W.Y., Chen J.Y., Chien C.T., Chi C.S., Han N.T. Eosinophilic meningitis caused by Angiostrongylus cantonensis. Pediatr. Infect. Dis. J. 1990, 9:443-445.
14. Hwang K.P., Chen E.R. Larvicidal effect of albendazole against Angiostrongylus cantonensis in mice. Am. J. Trop. Med. Hyg. 1988, 39:191-195.
15. Jantzie L.L., Cheung P.Y., Todd K.G. Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia. J. Cereb. Blood Flow Metab. 2005, 25:314-324.
16. Kieseier B.C., Paul R., Koedel U., Seifert T., Clements J.M., Gearing A.J., Pfister H.W., Hartung H.P. Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 1999, 122:1579-1587.
17. Kurzepa J., Bartosik-Psujek H., Suchozebrska-Jesionek D., Rejdak K., Stryjecka-Zimmer M., Stelmasiak Z. Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis. Neurol. Neurochir. Pol. 2005, 39:63-67.
18. Lammie G.A. Pathology of small vessel stroke. Br. Med. Bull. 2000, 56:296-306.
19. Lee H.H., Chou H.L., Chen K.M., Lai S.C. Association of matrix metalloproteinase-9 in eosinophilic meningitis of BALB/c mice caused by Angiostrongylus cantonensis. Parasitol. Res. 2004, 94:321-328.
20. Lukes A., Mun-Bryce S., Lukes M., Rosenberg G.A. Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol. Neurobiol. 1999, 19:267-284.
21. Mackerras M.J., Sandars D.F. Life history of the rat lung-worm and its migration through the brain of its host. Nature 1954, 173:956-957.
22. Mandal M., Mandal A., Das S., Chakraborti T., Sajal C. Clinical implications of matrix metalloproteinases. Mol. Cell. Biochem. 2003, 252:305-329.
23. Nicoloff G., Baydanoff S., Stanimirova N., Petrova C., Christova P. An association of anti-elastin IgA antibodies with development of retinopathy in diabetic children. Gen. Pharmacol. 2000, 35:83-87.
24. Nicoloff G., Tzvetanov P., Christova P., Baydanoff S. Detection of elastin derived peptides in cerebrospinal fluid of patients with first ever ischaemic stroke. Neuropeptides 2008, 42:277-282.
25. Pagenstecher A., Stalder A.K., Kincaid C.L., Shapiro S.D., Campbell I.L. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am. J. Pathol. 1998, 152:729-741.
26. Parsons J.C., Grieve R.B. Effect of egg dosage and host genotype on liver trapping in murine larval toxocariasis. J. Parasitol. 1990, 76:53-58.
27. Raffetto J.D., Khalil R.A. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem. Pharmacol. 2008, 75:346-359.
28. Robert L., Jacob M.P., Frances C., Godeau G., Hornebeck W. Interaction between elastin and elastase and its role in the aging of the arterial wall, skin and other connective tissues. Mech. Ageing Dev. 1984, 28:155-166.
29. Rosenbloom J. Elastin: relation of protein and gene structure to disease. Lab. Invest. 1984, 51:605-623.
30. Sajanti J., Majamaa K. Detection of meningeal fibrosis after subarachnoid haemorrhage by assaying procollagen propeptides in cerebrospinal fluid. J. Neurol. Neurosurg. Psychiatry 1999, 67:185-188.
31. Satta J., Laurila A., Pääkkö P., Haukipuro K., Sormunen R., Parkkila S., Juvonen T. Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: an immunohistochemical and electron microscopic study. Eur. J. Vasc. Endovasc. Surg. 1998, 15:313-319.
32. Sehba F.A., Mostafa G., Knopman J., Friedrich V., Bederson J.B. Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J. Neurosurg. 2004, 101:633-640.
33. Shapiro S.D. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 1998, 10:602-608.
34. Tzvetanov P., Nicoloff G., Rousseff R., Christova P. Increased levels of elastin-derived peptides in cerebrospinal fluid of patients with lacunar stroke. Clin. Neurol. Neurosurg. 2008, 110:239-244.
35. Vaalamo M., Kariniemi A.L., Shapiro S.D., Saarialho-Kere U. Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. J. Invest. Dermatol. 1999, 112:499-505.
36. Vacek T.P., Gillespie W., Tyagi N., Vacek J.C., Tyagi S.C. Hydrogen sulfide protects against vascular remodeling from endothelial damage. Amino Acids 2010, 39:1161-1169.
37. Venkatesan P. Albendazole. J. Antimicrob. Chemother. 1998, 41:145-147.
38. Wardlaw J.M., Sandercock P.A., Denis M.S., Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?. Stroke 2003, 34:806-812.
39. Yrjänheikki J., Keinänen R., Pellikka M., Hökfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. USA 1998, 95:15769-15774.